Related Experiment Video
Updated: Feb 6, 2026

Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts
Published on: December 17, 2016
Ectopic overexpression of Kir6.1 in the mouse heart impacts on the life expectancy
Yasuhiro Watanabe1, Takashi Kishimoto2, Takashi Miki3
1Department of Pharmacology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Insights
Transgenic mice overexpressing the vascular type ATP-sensitive potassium (KATP) channel subunit (Kir6.1) showed normal heart function initially but later developed cardiac fibrosis, conduction delays, and premature death, revealing a novel KATP channel dysfunction disease model.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Ion Channel Physiology
Background:
- Cardiac ATP-sensitive potassium (KATP) channels are crucial for heart function.
- Dysfunction of cardiac KATP channels is implicated in human cardiomyopathies.
- The role of the vascular subtype KATP channel subunit (Kir6.1) in cardiac health is not fully understood.
Purpose of the Study:
- To investigate the long-term effects of overexpressing Kir6.1 on cardiac function and pathology.
- To establish a transgenic mouse model for studying KATP channel-related cardiac disease.
- To elucidate the electrophysiological and pathological mechanisms underlying KATP channel dysfunction.
Main Methods:
- Generation and long-term observation of transgenic mice overexpressing Kir6.1.
- Surface electrocardiography (ECG) at rest and under stress (noradrenaline).
- Histological analysis for cardiac fibrosis and gene expression profiling.
Main Results:
- Transgenic mice exhibited normal sinus rhythm but prolonged QT intervals.
- Stress ECG revealed intraventricular conduction delay and arrhythmogeneity.
- Aged transgenic mice developed significant cardiac fibrosis and elevated cytokine and BNP expression.
Conclusions:
- Overexpression of Kir6.1 leads to progressive cardiac pathology and premature mortality.
- Kir6.1TG mice serve as a valuable model for KATP channel dysfunction-induced cardiac disease.
- Early molecular changes precede overt fibrosis, offering insights into disease progression.
Abstract:
We recently reported the reduced ATP-sensitive potassium (KATP) channel activities in the transgenic mouse heart overexpressing the vascular type KATP channel pore-forming subunit (Kir6.1). Although dysfunction of cardiac KATP channel has been nominated as a cause of cardiomyopathy in human, these transgenic mice looked normal as wild-type (WT) during the experiment period (~20 weeks). Extended observation period revealed unexpected deaths beginning from 30 weeks and about 50% of the transgenic mice died by 55 weeks. Surface ECG recordings from the transgenic mice at rest demonstrated the normal sinus rhythm and the regular ECG complex as well as the control WT mice except for prolonged QT interval. However, the stress ECG test with noradrenaline revealed abnormal intraventricular conduction delay and arrhythmogeneity in the transgenic mouse. Fibrotic changes in the heart tissue were remarkable in aged transgenic mice, and the cardiac fibrosis developed progressively at least from the age of 30 weeks. Gene expression analyses revealed the differentiation of cardiac fibroblasts to myofibroblasts with elevated cytokine expressions was initiated way in advance before the fibrotic changes and the upregulation of BNP in the ventricle. In sum, Kir6.1TG mice provide an electro-pathological disease concept originated from KATP channel dysfunction.
Related Concept Videos
Expected Value
Half-life of a Reaction
Characteristics of Life
The Angiosperm Life Cycle
Determination of Expected Frequency
Impact of Groups on Groups

